BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25937441)

  • 21. Breaking up is hard to do: tenecteplase in acute stroke.
    Schwamm LH
    Lancet Neurol; 2015 Apr; 14(4):343-5. PubMed ID: 25726503
    [No Abstract]   [Full Text] [Related]  

  • 22. Door-to-needle times in acute ischemic stroke: how low can we go?
    Smith EE; von Kummer R
    Neurology; 2012 Jul; 79(4):296-7. PubMed ID: 22622861
    [No Abstract]   [Full Text] [Related]  

  • 23. Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase.
    Fiebach JB; Al-Rawi Y; Wintermark M; Furlan AJ; Rowley HA; Lindstén A; Smyej J; Eng P; Warach S; Pedraza S
    Stroke; 2012 Jun; 43(6):1561-6. PubMed ID: 22474060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
    Freeman R; Niego B; Croucher DR; Pedersen LO; Medcalf RL
    Brain Res; 2014 May; 1565():63-73. PubMed ID: 24675027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to letter regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
    Liao X; Wang Y; Wang Y
    Stroke; 2014 Dec; 45(12):e304. PubMed ID: 25342031
    [No Abstract]   [Full Text] [Related]  

  • 26. rt-PA for ischaemic stroke: what will the next question be?
    Leys D; Cordonnier C
    Lancet; 2012 Jun; 379(9834):2320-1. PubMed ID: 22632906
    [No Abstract]   [Full Text] [Related]  

  • 27. There is sufficient evidence to support intra-arterial therapy of ischemic stroke.
    Furlan AJ
    J Neurointerv Surg; 2012 May; 4(3):167-8. PubMed ID: 22427187
    [No Abstract]   [Full Text] [Related]  

  • 28. Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
    Chao AC; Po HL; Chan L
    Stroke; 2014 Dec; 45(12):e303. PubMed ID: 25342029
    [No Abstract]   [Full Text] [Related]  

  • 29. Advanced Brain Imaging in Late-Arriving Drip and Ship Patients With Known Large Vessel Occlusion.
    Albers GW; Molina CA; Selim MH; Jovin TG
    Stroke; 2019 Jul; 50(7):1940-1943. PubMed ID: 31216963
    [No Abstract]   [Full Text] [Related]  

  • 30. IV thrombolysis for acute ischemic stroke: Is there a paradigm shift on the horizon?
    Barrett KM; Gottesman RF
    Neurology; 2016 Jul; 87(2):132-3. PubMed ID: 27306635
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thrombolytic therapy in acute ischemic stroke: present and future].
    Mori E
    No Shinkei Geka; 2003 Mar; 31(3):249-60. PubMed ID: 12684978
    [No Abstract]   [Full Text] [Related]  

  • 32. Randomised trials of endovascular treatment of stroke are needed.
    Schott AM
    Lancet Neurol; 2010 Jan; 9(1):30-1. PubMed ID: 20083032
    [No Abstract]   [Full Text] [Related]  

  • 33. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. 2003.
    ;
    J Vasc Interv Radiol; 2003 Aug; 14(8):945-6. PubMed ID: 12902567
    [No Abstract]   [Full Text] [Related]  

  • 34. Intra-arterial therapies for acute ischemic stroke: unsafe and without proven value.
    Powers WJ
    J Neurointerv Surg; 2012 May; 4(3):164-6. PubMed ID: 22427186
    [No Abstract]   [Full Text] [Related]  

  • 35. Beyond IV thrombolysis for acute ischaemic stroke.
    Blacker DJ; Phatouros CC
    Intern Med J; 2011 Aug; 41(8):645. PubMed ID: 21831124
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arterial recanalization benefits even neurologically improving stroke patients after intravenous tissue-type plasminogen activator.
    Esfahani DR; Kashyap S; Alaraj A; Amin-Hanjani S
    World Neurosurg; 2014 Feb; 81(2):208-9. PubMed ID: 24355519
    [No Abstract]   [Full Text] [Related]  

  • 38. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents.
    Samaniego EA; Linfante I; Dabus G
    Tech Vasc Interv Radiol; 2012 Mar; 15(1):41-6. PubMed ID: 22464301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Schestatsky P; Picon PD
    Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16344546
    [No Abstract]   [Full Text] [Related]  

  • 40. Induced hypertension in patients with partial recanalization after intra-arterial thrombolysis for acute ischemic stroke.
    Shah QA; Patel S; Qureshi AI
    J Neurosurg Anesthesiol; 2008 Apr; 20(2):154-5. PubMed ID: 18362784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.